242 related articles for article (PubMed ID: 11888913)
1. Marked prevention of tumor growth and metastasis by a novel immunosuppressive agent, FTY720, in mouse breast cancer models.
Azuma H; Takahara S; Ichimaru N; Wang JD; Itoh Y; Otsuki Y; Morimoto J; Fukui R; Hoshiga M; Ishihara T; Nonomura N; Suzuki S; Okuyama A; Katsuoka Y
Cancer Res; 2002 Mar; 62(5):1410-9. PubMed ID: 11888913
[TBL] [Abstract][Full Text] [Related]
2. Selective cancer cell apoptosis induced by FTY720; evidence for a Bcl-dependent pathway and impairment in ERK activity.
Azuma H; Horie S; Muto S; Otsuki Y; Matsumoto K; Morimoto J; Gotoh R; Okuyama A; Suzuki S; Katsuoka Y; Takahara S
Anticancer Res; 2003; 23(4):3183-93. PubMed ID: 12926052
[TBL] [Abstract][Full Text] [Related]
3. Induction of apoptosis in human bladder cancer cells in vitro and in vivo caused by FTY720 treatment.
Azuma H; Takahara S; Horie S; Muto S; Otsuki Y; Katsuoka Y
J Urol; 2003 Jun; 169(6):2372-7. PubMed ID: 12771800
[TBL] [Abstract][Full Text] [Related]
4. FTY720 induced Bcl-associated and Fas-independent apoptosis in human renal cancer cells in vitro and significantly reduced in vivo tumor growth in mouse xenograft.
Ubai T; Azuma H; Kotake Y; Inamoto T; Takahara K; Ito Y; Kiyama S; Sakamoto T; Horie S; Muto S; Takahara S; Otsuki Y; Katsuoka Y
Anticancer Res; 2007; 27(1A):75-88. PubMed ID: 17352219
[TBL] [Abstract][Full Text] [Related]
5. FTY720, a synthetic compound from Isaria sinclairii, inhibits proliferation and induces apoptosis in pancreatic cancer cells.
Shen Y; Cai M; Xia W; Liu J; Zhang Q; Xie H; Wang C; Wang X; Zheng S
Cancer Lett; 2007 Sep; 254(2):288-97. PubMed ID: 17462818
[TBL] [Abstract][Full Text] [Related]
6. FTY720 (fingolimod) sensitizes prostate cancer cells to radiotherapy by inhibition of sphingosine kinase-1.
Pchejetski D; Bohler T; Brizuela L; Sauer L; Doumerc N; Golzio M; Salunkhe V; Teissié J; Malavaud B; Waxman J; Cuvillier O
Cancer Res; 2010 Nov; 70(21):8651-61. PubMed ID: 20959468
[TBL] [Abstract][Full Text] [Related]
7. Marked suppression of tumor growth by FTY720 in a rat liver tumor model: the significance of down-regulation of cell survival Akt pathway.
Ng KT; Man K; Ho JW; Sun CK; Lee TK; Zhao Y; Lo CM; Poon RT; Fan ST
Int J Oncol; 2007 Feb; 30(2):375-80. PubMed ID: 17203219
[TBL] [Abstract][Full Text] [Related]
8. Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cells.
Azuma H; Ehata S; Miyazaki H; Watabe T; Maruyama O; Imamura T; Sakamoto T; Kiyama S; Kiyama Y; Ubai T; Inamoto T; Takahara S; Itoh Y; Otsuki Y; Katsuoka Y; Miyazono K; Horie S
J Natl Cancer Inst; 2005 Dec; 97(23):1734-46. PubMed ID: 16333029
[TBL] [Abstract][Full Text] [Related]
9. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S
J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011
[TBL] [Abstract][Full Text] [Related]
10. FTY720: a promising agent for treatment of metastatic hepatocellular carcinoma.
Lee TK; Man K; Ho JW; Wang XH; Poon RT; Xu Y; Ng KT; Chu AC; Sun CK; Ng IO; Sun HC; Tang ZY; Xu R; Fan ST
Clin Cancer Res; 2005 Dec; 11(23):8458-66. PubMed ID: 16322309
[TBL] [Abstract][Full Text] [Related]
11. FTY720, a fungus metabolite, inhibits invasion ability of androgen-independent prostate cancer cells through inactivation of RhoA-GTPase.
Zhou C; Ling MT; Kin-Wah Lee T; Man K; Wang X; Wong YC
Cancer Lett; 2006 Feb; 233(1):36-47. PubMed ID: 16473668
[TBL] [Abstract][Full Text] [Related]
12. FTY720 induces apoptosis in multiple myeloma cells and overcomes drug resistance.
Yasui H; Hideshima T; Raje N; Roccaro AM; Shiraishi N; Kumar S; Hamasaki M; Ishitsuka K; Tai YT; Podar K; Catley L; Mitsiades CS; Richardson PG; Albert R; Brinkmann V; Chauhan D; Anderson KC
Cancer Res; 2005 Aug; 65(16):7478-84. PubMed ID: 16103102
[TBL] [Abstract][Full Text] [Related]
13. Suppression of androgen-independent prostate cancer cell aggressiveness by FTY720: validating Runx2 as a potential antimetastatic drug screening platform.
Chua CW; Chiu YT; Yuen HF; Chan KW; Man K; Wang X; Ling MT; Wong YC
Clin Cancer Res; 2009 Jul; 15(13):4322-35. PubMed ID: 19509141
[TBL] [Abstract][Full Text] [Related]
14. Antagonism of sphingosine-1-phosphate receptors by FTY720 inhibits angiogenesis and tumor vascularization.
LaMontagne K; Littlewood-Evans A; Schnell C; O'Reilly T; Wyder L; Sanchez T; Probst B; Butler J; Wood A; Liau G; Billy E; Theuer A; Hla T; Wood J
Cancer Res; 2006 Jan; 66(1):221-31. PubMed ID: 16397235
[TBL] [Abstract][Full Text] [Related]
15. Lovastatin inhibits tumor growth and lung metastasis in mouse mammary carcinoma model: a p53-independent mitochondrial-mediated apoptotic mechanism.
Shibata MA; Ito Y; Morimoto J; Otsuki Y
Carcinogenesis; 2004 Oct; 25(10):1887-98. PubMed ID: 15180944
[TBL] [Abstract][Full Text] [Related]
16. Effect of FTY720 on apoptosis of smooth muscle cells.
Böhler T; Guillebaud J; Etienne L; Canivet C; Kamar N; Rostaing L; Thiers JC; Galvani S; Augé N; Salvayre R; Nègre-Salvayre A; Thomsen M
Transplant Proc; 2007 Oct; 39(8):2624-6. PubMed ID: 17954194
[TBL] [Abstract][Full Text] [Related]
17. FTY720 ameliorates oxazolone colitis in mice by directly affecting T helper type 2 functions.
Daniel C; Sartory NA; Zahn N; Schmidt R; Geisslinger G; Radeke HH; Stein JM
Mol Immunol; 2007 Jul; 44(13):3305-16. PubMed ID: 17475330
[TBL] [Abstract][Full Text] [Related]
18. Evidence that FTY720 induces rat thymocyte apoptosis.
Isoyama N; Takai K; Tsuchida M; Matsumura M; Naito K
Transpl Immunol; 2006 Apr; 15(4):265-71. PubMed ID: 16635748
[TBL] [Abstract][Full Text] [Related]
19. FTY720 inhibits tumor growth and angiogenesis.
Schmid G; Guba M; Papyan A; Ischenko I; Brückel M; Bruns CJ; Jauch KW; Graeb C
Transplant Proc; 2005; 37(1):110-1. PubMed ID: 15808563
[TBL] [Abstract][Full Text] [Related]
20. FTY720 induces apoptosis in hepatocellular carcinoma cells through activation of protein kinase C delta signaling.
Hung JH; Lu YS; Wang YC; Ma YH; Wang DS; Kulp SK; Muthusamy N; Byrd JC; Cheng AL; Chen CS
Cancer Res; 2008 Feb; 68(4):1204-12. PubMed ID: 18281497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
